SEC Contract Filing

Filing Date: 2021-12-08

Document Content:
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>8
<FILENAME>d225964dex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNIT PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This UNIT PURCHASE AGREEMENT (this &#147;<B>Agreement</B>&#148;) is made as of the 2 day of December 2021, by and between BioPlus Acquisition
Corp., a Cayman Islands exempted company (the &#147;<B>Company</B>&#148;), having its principal place of business at 260 Madison Avenue, Suite 800, New York, NY 10016, and&nbsp;BioPlus Sponsor LLC, a Cayman Islands limited liability company, having
its principal place of business at 533 Airport Blvd, Suite 400, Burlingame, CA 94010 (the &#147;<B>Subscriber</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the
Company desires to sell on a private placement basis (the &#147;<B>Offering</B>&#148;) an aggregate of 380,000 units (&#147;<B>Units</B>&#148;) of the Company, each Unit comprised of one Class&nbsp;A ordinary share of the Company, par value $0.0001
per share (&#147;<B>Ordinary Shares</B>&#148;), and one half of one warrant to purchase one Class&nbsp;A ordinary share (&#147;<B>Warrant</B>&#148;), for a purchase price of $3,800,000, or $10.00 per Unit. The Ordinary Shares underlying the Warrants
are hereinafter referred to as the &#147;<B>Warrant Shares</B>.&#148;&nbsp;The Ordinary Shares underlying the Units (excluding the Warrant Shares) are hereinafter referred to as the &#147;<B>Placement Shares</B>.&#148; The Warrants underlying the
Units are hereinafter referred to as the &#147;<B>Placement Warrants</B>.&#148;&nbsp;The Units, Placement Shares, Placement Warrants and Warrant Shares, collectively, are hereinafter referred to as the &#147;<B>Securities</B>.&#148;&nbsp;Placement
Warrants may be exercised only to the extent that, when aggregated with other Placement Warrants being exercised, the exercise is for a whole share or whole shares; no fractional shares shall be issuable. The exercise price for any Warrant Share
shall be $11.50. Subject to the foregoing, the Placement Warrants are exercisable during the period commencing 30 days following the completion of the Company&#146;s initial business combination (the &#147;<B>Business Combination</B>&#148;), as such
term is defined in the registration statement filed in connection with the IPO, as amended at the time it becomes effective (the &#147;<B>Registration Statement</B>&#148;), and expiring on the fifth anniversary of the completion of the Business
Combination; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Subscriber wishes to purchase the Units from the Company and the Company wishes to accept such subscription
from the Subscriber. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises and the mutual covenants hereinafter set forth and other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Subscriber hereby agree as follows: </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Agreement to Subscribe</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>1.1 Purchase and Issuance of the Units.</B>&nbsp;Upon the terms and subject to the conditions of this Agreement, the Subscriber hereby
agrees to purchase from the Company, and the Company hereby agrees to sell to the Subscriber, simultaneously with the closing of the IPO on or before December&nbsp;7, 2021 (the &#147;<B>Initial Closing Date</B>&#148;), 380,000 Units for a purchase
price of $3,800,000 (the &#147;<B>Purchase Price</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>1.2 Delivery of the Purchase Price.</B>&nbsp;Upon execution of this
Agreement, the Company is bound to fulfill its obligations hereunder and the Subscriber hereby irrevocably commits to deliver directly into a trust account (the<B>&nbsp;&#147;Trust Account&#148;</B><B></B>&nbsp;) held at JP Morgan Chase Bank, N.A.
or any other financial institution chosen by the Company, with Continental Stock Transfer&nbsp;&amp; Trust Company acting as trustee (&#147;<B>Continental</B>&#148;), the Purchase Price in immediately available funds by wire transfer or such other
form of payment as shall be acceptable to Continental, in its sole and absolute discretion, one (1)&nbsp;business day prior to the effective date of the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>1.3 Termination.</B>&nbsp;This Agreement and each of the obligations of the undersigned shall be null and void and without effect if the
Closing does not occur prior to June&nbsp;30, 2022. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BOR